Publications by authors named "Ariel Fu"

Claim this Profile
I
Insights on Hospitalisations from the Phase 3a ONWARDS 1-6 Trials of Once-Weekly Insulin Icodec.
Athena Philis-Tsimikas, Julie Krogsdahl Bache, Ariel Fu, Monika Kellerer, Karen Salvesen-Sykes

Diabetes Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial.
Ildiko Lingvay, Malik Benamar, Liming Chen, Ariel Fu, Esteban Jódar

Diabetologia· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and hypoglycaemia outcomes with once-weekly insulin icodec versus once-daily basal insulin in type 2 diabetes according to baseline glucagon-like peptide-1 receptor agonist and sodium-glucose co-transporter-2 inhibitor use: A post hoc analysis of ONWARDS 1-5.
Tina Vilsbøll, Ariel Fu, Monika Kellerer, Bharath Kumar, Stinne Byrholdt Søgaard

Diabetes Obes Metab· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial.
Ildiko Lingvay, Malik Benamar, Liming Chen, Ariel Fu, Esteban Jódar

Diabetologia· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic properties of once-weekly insulin icodec in Chinese individuals with type 2 diabetes.
Yijun Li, Ariel Fu, Shan Jiang, Ann-Katrine Kjærsgaard Jøns, Beibei Liang

J Diabetes Investig· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis